{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:57:30Z","timestamp":1786672650754,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00246-024-03641-3","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T14:03:35Z","timestamp":1726149815000},"page":"2283-2290","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Real-World Use and Outcomes of Apixaban for Early Post-Surgical Fontan Thromboprophylaxis"],"prefix":"10.1007","volume":"46","author":[{"given":"Kira","family":"Adkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Esteso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberlee","family":"Gauvreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"VanderPluym","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Hellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"3","key":"3641_CR1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/thx.26.3.240","volume":"26","author":"F Fontan","year":"1971","unstructured":"Fontan F, Baudet E (1971) Surgical repair of tricuspid atresia. Thorax 26(3):240\u2013248. https:\/\/doi.org\/10.1136\/thx.26.3.240","journal-title":"Thorax"},{"key":"3641_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5223(19)37498-7","author":"F Fontan","year":"1983","unstructured":"Fontan F, Deville C, Quaegebeur A et al (1983) Repair of tricuspid atresia in 100 patients. J Thorac Cardiovas Surg. https:\/\/doi.org\/10.1016\/s0022-5223(19)37498-7","journal-title":"J Thorac Cardiovas Surg"},{"key":"3641_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.9.287","author":"DN Rosenthal","year":"1995","unstructured":"Rosenthal DN, Friedman AH, Kleinman CS, Kopf GS, Rosenfeld LE, Hellenbrand WE (1995) Thromboembolic complications after Fontan operations. Circulation. https:\/\/doi.org\/10.1161\/01.CIR.92.9.287","journal-title":"Circulation"},{"issue":"6","key":"3641_CR4","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/S0003-4975(01)02472-9","volume":"71","author":"PD Coon","year":"2001","unstructured":"Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL (2001) Thrombus formation after the Fontan operation. Ann Thorac Surg 71(6):1990\u20131994. https:\/\/doi.org\/10.1016\/S0003-4975(01)02472-9","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"3641_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0022-5223(97)70283-6","volume":"113","author":"M Jahangiri","year":"1997","unstructured":"Jahangiri M, Shore D, Kakkar V et al (1997) Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 113(6):989\u2013993. https:\/\/doi.org\/10.1016\/S0022-5223(97)70283-6","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3641_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.738559","author":"P Khairy","year":"2008","unstructured":"Khairy P, Fernandes SM, Mayer JE et al (2008) Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.738559","journal-title":"Circulation"},{"key":"3641_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.021765","author":"BW McCrindle","year":"2021","unstructured":"McCrindle BW, Michelson AD, Van Bergen AH et al (2021) Thromboprophylaxis for children post-fontan procedure: insights from the UNIVERSE study. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.120.021765","journal-title":"J Am Heart Assoc"},{"key":"3641_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2022.01.028","author":"JF Heidendael","year":"2022","unstructured":"Heidendael JF, Engele LJ, Bouma BJ et al (2022) Coagulation and anticoagulation in Fontan patients. Can J Cardiol. https:\/\/doi.org\/10.1016\/j.cjca.2022.01.028","journal-title":"Can J Cardiol"},{"issue":"24","key":"3641_CR9","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1161\/01.CIR.0000436140.77832.7A","volume":"128","author":"TM Giglia","year":"2013","unstructured":"Giglia TM, Massicotte MP, Tweddell JS et al (2013) Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American heart association. Circulation 128(24):2622\u20132703. https:\/\/doi.org\/10.1161\/01.CIR.0000436140.77832.7A","journal-title":"Circulation"},{"key":"3641_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ppedcard.2005.09.003","volume":"21","author":"P Monagle","year":"2005","unstructured":"Monagle P (2005) Thrombosis in children with BT shunts, Glenns and Fontans. Prog Pediatr Cardiol 21:17\u201321","journal-title":"Prog Pediatr Cardiol"},{"issue":"1","key":"3641_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/S00246-010-9808-4","volume":"32","author":"C Marrone","year":"2011","unstructured":"Marrone C, Galasso G, Piccolo R et al (2011) Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis. Pediatr Cardiol 32(1):32\u201339. https:\/\/doi.org\/10.1007\/S00246-010-9808-4","journal-title":"Pediatr Cardiol"},{"key":"3641_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-022-02848-6","author":"K Miwa","year":"2022","unstructured":"Miwa K, Iwai S, Nagashima T (2022) Anticoagulation therapy after the Fontan procedure. Pediatr Cardiol. https:\/\/doi.org\/10.1007\/s00246-022-02848-6","journal-title":"Pediatr Cardiol"},{"key":"3641_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.803408","author":"S Van Den Helm","year":"2022","unstructured":"Van Den Helm S, Sparks CN, Ignjatovic V, Monagle P, Attard C (2022) Increased risk for thromboembolism after Fontan surgery: considerations for thromboprophylaxis. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2022.803408","journal-title":"Front Pediatr"},{"issue":"4","key":"3641_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00246-014-1089-x","volume":"36","author":"JM Murray","year":"2015","unstructured":"Murray JM, Hellinger A, Dionne R et al (2015) Utility of a dedicated pediatric cardiac anticoagulation program: the Boston children\u2019s hospital experience. Pediatr Cardiol 36(4):842\u2013850. https:\/\/doi.org\/10.1007\/s00246-014-1089-x","journal-title":"Pediatr Cardiol"},{"key":"3641_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/J.AHJ.2019.08.002","volume":"217","author":"RM Payne","year":"2019","unstructured":"Payne RM, Burns KM, Glatz AC et al (2019) A multi-national trial of a direct oral anticoagulant in children with cardiac disease: design and rationale of the safety of apixaban on pediatric heart disease on the prevention of embolism (SAXOPHONE) study. Am Heart J 217:52\u201363. https:\/\/doi.org\/10.1016\/J.AHJ.2019.08.002","journal-title":"Am Heart J"},{"key":"3641_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/J.JTHA.2023.03.005","author":"C VanderPluym","year":"2023","unstructured":"VanderPluym C, Esteso P, Ankola A et al (2023) Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease. J Thromb Haemost. https:\/\/doi.org\/10.1016\/J.JTHA.2023.03.005","journal-title":"J Thromb Haemost"},{"issue":"11","key":"3641_CR17","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/JTH.13140","volume":"13","author":"S Kaatz","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S (2015) Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 13(11):2119\u20132126. https:\/\/doi.org\/10.1111\/JTH.13140","journal-title":"J Thromb Haemost"},{"key":"3641_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692\u2013694","journal-title":"J Thromb Haemost"},{"issue":"8","key":"3641_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","volume":"132","author":"A Avezum","year":"2015","unstructured":"Avezum A, Lopes RD, Schulte PJ et al (2015) Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (Aristotle) trial. Circulation 132(8):624\u2013632. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.014807","journal-title":"Circulation"},{"issue":"10","key":"3641_CR20","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1111\/jth.12372","volume":"11","author":"C Attard","year":"2013","unstructured":"Attard C, van der Straaten T, Karlaftis V, Monagle P, Ignjatovic V (2013) Developmental hemostasis: age-specific differences in the levels of hemostatic proteins. J Thromb Haemost 11(10):1850\u20131854. https:\/\/doi.org\/10.1111\/jth.12372","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3641_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2003-42584","volume":"29","author":"S Kuhle","year":"2003","unstructured":"Kuhle S, Male C, Mitchell L (2003) Developmental hemostasis: pro-and anticoagulant systems during childhood. Semin Thromb Hemost 29(4):329\u2013337. https:\/\/doi.org\/10.1055\/s-2003-42584","journal-title":"Semin Thromb Hemost"},{"key":"3641_CR22","first-page":"723","volume-title":"Seminars in Thrombosis and Hemostasis","author":"V Ignjatovic","year":"2011","unstructured":"Ignjatovic V, Mertyn E, Monagle P (2011) The coagulation system in children: Developmental and pathophysiological considerations. Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers, pp 723\u2013729"},{"issue":"5","key":"3641_CR23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/BCP.12541","volume":"79","author":"CE Frost","year":"2015","unstructured":"Frost CE, Byon W, Song Y et al (2015) Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. Br J Clin Pharmacol 79(5):838. https:\/\/doi.org\/10.1111\/BCP.12541","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"3641_CR24","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/S40262-019-00775-Z","volume":"58","author":"W Byon","year":"2019","unstructured":"Byon W, Garonzik S, Boyd RA, Frost CE (2019) Apixaban: a clinical pharmacokinetic and pharmacodynamic review. Clin Pharmacokinet 58(10):1265. https:\/\/doi.org\/10.1007\/S40262-019-00775-Z","journal-title":"Clin Pharmacokinet"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-024-03641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-024-03641-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-024-03641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:17:54Z","timestamp":1762157874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-024-03641-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3641"],"URL":"https:\/\/doi.org\/10.1007\/s00246-024-03641-3","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing financial or non-financial interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Ethical approval and informed consent were waived by Boston Children\u2019s Hospital IRB in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}